Literature DB >> 3544361

Treatment of imported cases of falciparum malaria in France with halofantrine.

J P Coulaud, J Le Bras, S Matheron, B Moriniere, A G Saimot, J F Rossignol.   

Abstract

Halofantrine is a 9-phenanthrenemethanol which is effective against multi-drug resistant strains of Plasmodium falciparum. It has been shown to be highly effective and extremely well tolerated in the treatment of imported cases of falciparum malaria in France. A total of 1,500 mg administered in three 500 mg doses at six-hour intervals results in a 100% cure rate in semi-immune subjects. This dosage should be repeated after 14 days to obtain the same cure rate in non-immune patients. Minor clinical side effects included epigastric pains, nausea and, in one case, a skin rash.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3544361     DOI: 10.1016/0035-9203(86)90158-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

Review 1.  Halofantrine: a new substance for treatment of multidrug-resistant malaria.

Authors:  H D Nothdurft; R Clemens; H L Bock; T Löscher
Journal:  Clin Investig       Date:  1993-01

2.  A clinical trial with halofantrine on patients with falciparum malaria in Colombia.

Authors:  M Restrepo; D Botero; R E Marquez; E F Boudreau; V Navaratnam
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

3.  Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria.

Authors:  J Karbwang; K A Milton; K Na Bangchang; S A Ward; G Edwards; D Bunnag
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

4.  Efficacy of micronized halofantrine in semi-immune patients with acute uncomplicated falciparum malaria in Cameroon.

Authors:  G Fadat; F J Louis; J P Louis; J Le Bras
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

Review 5.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 6.  Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; K L Goa
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of halofantrine.

Authors:  J Karbwang; K Na Bangchang
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

8.  Halofantrine efficacy in non-immune children with imported acute Plasmodium falciparum malaria Infection.

Authors:  Isabelle Hau; Sophie Seringe; Said Aberrane; France De la Rocque; Christophe Delacourt; Robert Cohen; Philippe Reinert; Philippe Ovetchkine
Journal:  Eur J Pediatr       Date:  2003-11-28       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.